Seminari VHIR - Dr. Marcos Malumbres "Targeting classical and novel CDKs for cancer therapy"

 
  Sala d'Actes, planta baixa, Hospital General —
14/05/2019
14/05/2019 -- From 15:30h to 17:00h
Organize :
Vall d'Hebron Institut de Recerca (VHIR)
Modality: Presencial
Share it:

Dr. Marcos Malumbres - Spanish National Cancer Research Centre (CNIO) Madrid

"Targeting classical and novel CDKs for cancer therapy"

Inhibition of the cell cycle kinases CDK4 and CDK6 is becoming a standard treatment in advanced breast cancer, and their effect in other tumor types is currently under preclinical and clinical scrutiny. Since CDK4/6 inhibitors display a limited effect in monotherapy, future applications very likely will benefit from finding effective combinations. DNA damaging or antimitotic drugs are the standard of care in multiple malignancies; however, they are not expected to cooperate with CDK4/6 inhibitors as the latter arrest cells at the G1 phase of the cell cycle, thus preventing the cytotoxic effect of these classical chemotherapeutic agents in S-phase or mitosis. We will discuss recent data supporting the possibilities of combining CDK inhibitors with classical chemotherapy in several tumor types including breast or pancreatic cancer. We will also review the possibilities for preventing resistance to these drugs by targeting other CDK family members, or new data suggesting a significant therapeutic value for less-studied CDKs in lung or liver cancer.

Host: Biomedical Research in Urology, anna.santamaria@vhir.org

 

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.